Action 603168 ZHEJIANG SHAPUAISI PHARMACEUTICAL CO.,LTD.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Zhejiang Shapuaisi Pharmaceutical Co.,Ltd.

Actions

603168

CNE100001TG0

Cours en clôture Shanghai S.E.
Autres places de cotation
 00:00:00 26/04/2024 		Varia. 5j. Varia. 1 janv.
8,7 CNY +1,99 % Graphique intraday de Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. +1,87 % -35,12 %
19/04 Zhejiang Shapuaisi Pharmaceutical Co. publie ses résultats pour l'exercice clos le 31 décembre 2023 CI
09/04 Shapuaisi Pharma obtient l'autorisation de mise sur le marché du collyre au chlorhydrate de moxifloxacine MT

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Shapuaisi Pharma Gets China's Nod to Market Sodium Hyaluronate Eye Drops
Shapuaisi Pharma Gets Marketing Authorization for Moxifloxacin Hydrochloride Eye Drops
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Shanghai Lechun Biotechnology Co., Ltd. sign a share transfer agreement to acquire a 14.5% stake in Advanced Sterile Solutions Biotechnology Co., Ltd. from Shanghai Changgeng Industrial Development Co., Ltd. and Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. for CNY 40.6 million.
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Taizhou Women and Children's Hospital Co., Ltd. announced that it expects to receive CNY 231.1828 million in funding from Zhejiang Shapuaisi Pharmaceutical Co.,Ltd.
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. agreed to acquire Qingdao Shikang Eye Hospital Co., Ltd. from Shanghai Fangzhi Medical Management Co., Ltd. for CNY 66.5 million
Zhejiang Shapuaisi Pharma Shareholder Boosts Stake Through $44 Million Deal
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. announced that it has received CNY 317.999993 million in funding from Shanghai Yanghe Investment Management Co., Ltd. and other investor.
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. announced that it expects to receive funding from Shanghai Yanghe Industrial Co., Ltd.
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021
Shanghai Tonghui Medical Management Co., Ltd. completed the acquisition of 5.43% stake in Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. from Chen Dekang.
Shanghai Tonghui Medical Management Co., Ltd. signed a share transfer agreement to acquire 5.43% stake in Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. from Chen Dekang for approximately CNY 400 million.
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 603168
  4. Actualités Zhejiang Shapuaisi Pharmaceutical Co.,Ltd.
  5. Autres langues